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Abstract
The insulin-like growth factor signalling pathway is an important regulator of skeletal muscle growth. We examined the
mRNA expression of components of the insulin-like growth factor (IGF) signalling pathway as well as Fibroblast Growth
Factor 2 (FGF2) during maturation of myotubes in primary cell cultures isolated from fast myotomal muscle of Atlantic
salmon (Salmo salar). The transcriptional regulation of IGFs and IGFBP expression by amino acids and insulin-like growth
factors was also investigated. Proliferation of cells was 15% d21 at days 2 and 3 of the culture, increasing to 66% d21 at day
6. Three clusters of elevated gene expression were observed during the maturation of the culture associated with mono-
nucleic cells (IGFBP5.1 and 5.2, IGFBP-6, IGFBP-rP1, IGFBP-2.2 and IGF-II), the initial proliferation phase (IGF-I, IGFBP-4, FGF2 and
IGF-IRb) and terminal differentiation and myotube production (IGF2R, IGF-IRa). In cells starved of amino acids and serum for
72 h, IGF-I mRNA decreased 10-fold which was reversed by amino acid replacement. Addition of IGF-I and amino acids to
starved cells resulted in an 18-fold increase in IGF-I mRNA indicating synergistic effects and the activation of additional
pathway(s) leading to IGF-I production via a positive feedback mechanism. IGF-II, IGFBP-5.1 and IGFBP-5.2 expression was
unchanged in starved cells, but increased with amino acid replacement. Synergistic increases in expression of IGFBP5.2 and
IGFBP-4, but not IGFBP5.1 were observed with addition of IGF-I, IGF-II or insulin and amino acids to the medium. IGF-I and
IGF-II directly stimulated IGFBP-6 expression, but not when amino acids were present. These findings indicate that amino
acids alone are sufficient to stimulate myogenesis in myoblasts and that IGF-I production is controlled by both endocrine
and paracrine pathways. A model depicting the transcriptional regulation of the IGF pathway in Atlantic salmon muscle
following feeding is proposed.
Citation: Bower NI, Johnston IA (2010) Transcriptional Regulation of the IGF Signaling Pathway by Amino Acids and Insulin-Like Growth Factors during
Myogenesis in Atlantic Salmon. PLoS ONE 5(6): e11100. doi:10.1371/journal.pone.0011100
Editor: Gianni Parise, McMaster University, Canada
Received February 22, 2010; Accepted May 19, 2010; Published June 14, 2010
Copyright:  2010 Bower, Johnston. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the Biotechnology and Biological Research Council (grant BB/D015391/1). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nib@st-andrews.ac.uk
Introduction
Insulin-like growth factors (IGFs) and associated signaling
pathways play a central role in regulating skeletal muscle growth
in mammals [1,2]. The expansion of muscle fibres in length and
diameter is associated with net protein synthesis and nuclear
accretion from a population of proliferating myogenic precursor
cells [3,4]. IGF-I and IGF-II promote growth by stimulating
proliferation [5] and differentiation [6–8]. The IGF system
includes the hormones IGF-I, IGF-II, their corresponding
receptors and the IGF binding proteins (IGFBPs). Circulating
IGFs are present in serum and are primarily secreted from the
liver under the control of the pituitary/growth hormone axis [2],
however both hormones are also synthesised locally in numerous
tissues including skeletal muscle [9].
Stimulation of the cellular responses to IGF-I are mediated
through the IGF-I receptor via the PI3K/AKT/mTOR pathway
[8], with the availability of IGFs regulated by the insulin-like-
growth factor binding proteins (IGFBPs). The IGFBPs are a family
of secreted proteins with high affinity for IGFs with 6 distinct genes
characterised in several mammalian species [10–12]. IGFBPs are
expressed in different tissues throughout development and may
protect IGFs from proteolytic degradation. As the IGFBPs have a
higher affinity for the IGF ligand than its corresponding receptor,
they regulate the availability of IGF-I to bind with its receptor
[13]. The presence of certain domains in IGFBPs can facilitate
binding to proteins such as cell surface proteins and proteins
present in the extracellular matrix which results in reduced affinity
of IGFBPs for IGF-I [14,15]. Proteolytic degradation of IGFBPs
by specific proteases also results in release of IGF-I [14,16] thereby
targeting IGF-I to particular tissues, and to particular cell types
within those tissues. Different IGFBPs are known to stimulate and
inhibit IGF stimulated growth processes in different tissues and
developmental stages. For example, IGFBP-5 regulates the
differentiation of C2C12 myoblasts through binding to IGF-II
[17], whereas IGFBP-2 inhibits IGF-I stimulated cell proliferation
and DNA synthesis, and is considered a negative regulator of
growth [18]. IGF stimulation of processes such as differentiation
can also be affected by the presence or absence of other growth
factors. For example, basic fibroblast growth factor (bFGF) affects
IGF signalling by inhibiting differentiation [19–21] and promoting
cell proliferation [22]. In addition to stimulation by IGFs, the
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PI3K/AKT/mTOR pathway has recently been shown to be
nutritionally regulated, in that mTORC1 phosphorylation is
dependant on amino acid availability [23]. The amino acid leucine
is unique in its ability to stimulate phosphorylation of mTORC1
[24] but is dependent on the preloading of cells with glutamine to
facilitate leucine entry [25]. Several amino acid signalling
pathways have now been identified including vps34 [26],
recombination activating proteins (Rags) [27,28] and the ste-20
related mitogen-activated protein kinase kinase kinase kinase 3
(MAP4K3) [29].
Teleosts are ectotherms resulting in major differences in
metabolic regulation compared to mammals. For example, after
correcting for body size and depending on the temperature the
specific dynamic action can be 2–10 days, compared to a few
hours in mammals [30]. In addition many fish species undergo
long periods of fasting in the winter or during spawning migrations
during which time skeletal muscle wasting occurs as part of a
natural seasonal cycle [31–33]. It is therefore highly likely that the
regulation of muscle mass shows some differences compared to
mammals although the physiological mechanisms have yet to be
investigated in detail.
The genomes of teleost fish contain multiple copies of many genes
compared to mammals. This is because subsequent to divergence
from a common ancestor to the tetrapods, teleosts underwent whole
genome duplication (WGD), 320–350 million years ago, and
rediploidisation with approximately 15% of the duplicated genes
retained in extant species [34,35]. Following the WGD in basal
teleosts, an additional duplication event occurred 10–25 million years
ago in the salmonid lineage [36] resulting in the presence of up to four
salmonid paralogues for each mammalian gene. Of the duplicated
genes, 50% may have subsequently been lost from the salmonid
genome [37], with retained paralogues able to undergo sub-
functionalisation leading to altered expression patterns [38]. The
retention or loss of gene paralogues followingWGD is lineage specific
[38]. For example, there is one IGFBP-6 paralogue in Atlantic
salmon and two in the zebrafish genome, whereas both species have
retained two IGFBP-2 paralogues [39–41].
We have previously characterised the IGF signalling pathway in
Atlantic salmon (Salmo salar L.) identifying paralogues of IGFBP-2,
IGFBP-5, and IGF-I receptor [40]. In response to feeding, we
observed biphasic increased expression of IGF-I, early increased
expression of one IGFBP-5 paralogue and constitutive increased
expression of IGFBP-4. The aim of the present study was to use a
primary cell culture derived from fast skeletal muscle of Atlantic
salmon to investigate the transcriptional regulation of the IGF
components during myogenesis and obtain an insight into the roles
of gene paralogues. Manipulative experiments, involving amino
acid and serum withdrawal followed by addition of amino acids,
recombinant IGF-I, IGF-II and insulin in various combinations,
were used to investigate the nutritional and hormonal regulation of
the IGF-system.
Methods
Ethics Statement
All experiments were approved by the Animal Welfare
Committee of the University of St Andrews and fish were
humanely killed following Schedule 1 of the Animals (Scientific
Procedures) Act 1986 (Home Office Code of Practice. HMSO:
London January 1997).
Isolation of myogenic satellite cells
Fish used for cell culture were maintained in 1 m tanks at 10.8
C, and fed a commercially available fish diet (Ewos Innovation).
Myosatellite cells were isolated from juvenile Atlantic salmon
(Salmo salar L) 3066 g (mean 6s.d., N= 10 per preparation) using
a method similar to that previously described [42]. Fast myotomal
muscle was dissected under sterile conditions and placed in
extraction media consisting of Dulbecco’s modified eagle’s media
(DMEM) 9 mM NaHCO3, 20 mM HEPES (pH 7.4) with 15%
(v/v) horse serum and 1 x antibiotics (100 units/ml penicillin G,
100 mg/ml streptomycin sulfate, 0.25 mg/ml amphotericin B)
(Sigma, Gillingham, Dorset, UK) at a ratio of 1 gram of muscle
per 5 ml extraction media. The tissue was then minced with a
sterile scalpel before centrifugation at 300 g for 5 min, and two
washes with DMEM without horse serum. The muscle pieces were
digested with collagenase (0.2% m/v in DMEM, Type 1a, Sigma,
Gillingham, Dorset, UK) for 70 min at room temperature in the
dark, before centrifugation at 300 g for 5 minutes. The resulting
pellet was washed twice with DMEM before being passed through
a pipette repeatedly to separate cells.
Samples were further digested with trypsin (0.1 m/v % in
DMEM) for 20 minutes at room temperature. The resulting cell
suspension was centrifuged (300 g, 1 min). The supernatant was
poured into 20 x vol of extraction media containing serum to
inhibit trypsin activity. The pellet was further digested by a second
treatment with trypsin for 20 min at room temperature, before
centrifugation at 300 g 1 min. The supernatant was poured into
20 x volume of extraction media. The extraction media containing
the cell suspension was centrifuged at 300 g for 20 min. Cell
pellets were re-suspended in 30 ml of basal medium before
mechanical trituration through 10 ml and 5 ml pipettes until cells
were separated. The cell suspension was then passed through
100 mm and 40 mm nylon cell strainers (BD Biosciences San Jose,
CA, USA) and centrifuged 20 min 300 g. The cells were
resuspended in basal media, cell number determined using a
hymaecytometer, and then diluted to give approximately
1.56106 cells/ml.
Cell culture
All cell culture methods were performed using Aseptic
technique in a Microflow 2 Advanced biosafety cabinet (Bioquell
Ltd, Andover, UK). 6 well cell culture plates (Greiner Bio-One
Ltd, Stroudwater, UK) were treated with a 100 ug/ml poly-lysine
solution (Sigma, Gillingham, Dorset, UK) at 4 mg/cm2 for 5
minutes at room temperature, then aspirated before 2 washes with
sterile water and allowed to air dry. 1 ml of laminin (Sigma,
Gillingham, Dorset, UK) in DMEM at 20 mg/ml was applied to
each well and incubated at 18uC overnight prior to plated cells.
Cell culture was performed using complete medium (DMEM,
9 mM NaHCO3, 20 mM HEPES (pH 7.4), supplemented with
10% foetal calf serum (Sigma) and 1 x antibiotics (Sigma,
Gillingham, Dorset, UK) which was changed daily.
Cell starvation and treatments
Cells were grown until day 9, and then washed once with amino
acid deprived (starve) media (Earle’s balanced salt solution,
supplemented with 9 mM NaHCO3, 20 mM HEPES (pH 7.4),
2 g/l glucose, supplemented with 1 x vitamins, 1 x antibiotics), and
then grown for 72 h in starve media. Control cells were grown in
complete media. RNA was extracted from the cells 0, 6, 12, 24, 36,
48 and 72 h following treatment.
Cells starved for 72 h were then grown for 24 h in either starve
media (control), starve media supplemented with IGF-I (recom-
binant salmon protein, GroPep, Adelaide, Australia) (100 ng/ml)
or IGF-II (recombinant salmon protein, GroPep, Adelaide,
Australia) (100 ng/ml), amino acid media (DMEM, 9 mM
NaHCO3, 20 mM HEPES (pH 7.4), 1 x antibiotics), amino acid
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media with IGF-I (100 ng/ml), IGF-II (100 ng/ml) or IGF-I +
IGF-II (100 ng/ml each), and amino acid media with 1 uM
insulin (Sigma, Gillingham, Dorset, UK). RNA was extracted from
cells 0, 3, 6, 12 and 24 h following treatment.
Immunofluorescence of culture cells
Cells were grown on glass coverslips treated with poly-L-lysine and
laminin as described above. Samples were washed 2 x in PBS, fixed in
4% (m/v) paraformaldehyde for 20 min at room temperature,
washed 265 min in PBS, permeabilised with 0.2% triton X-100 PBS
for 5 minutes, washed 2 x in PBS and then blocked in 5%NGS, 1.5%
BSA, 0.1% triton X-100 PBS for 1 h at room temperature. All
antibody steps were performed in PBST (1%BSA, 0.1% triton X-100
in PBS). Desmin antibody (Sigma, Gillingham, Dorset, UK) was
diluted 1:20 and anti-BrdU Alexa Flour 546 antibody diluted 1:20
(Invitrogen, Carlsbad, CA, USA) in PBST and incubated overnight
at 4uC, washed 3 x in PBS. For visualisation of desmin, a 1:400
dilution of anti-rabbit Alexa Fluor 405 antibody (Invitrogen,
Carlsbad, CA, USA) in PBST was incubated for 1 h at room
temperature, and washed 3 x in PBS. Cells were then counterstained
for nuclei with Sytox green (Invitrogen, Carlsbad, CA, USA) as per
manufacturer’s recommendations. Cells were imaged using a Leica
TCS SP2 confocal microscope.
Cell proliferation analysis
Cell proliferation rates were calculated by culturing cells in the
presence of a 1:100 dilution of BrdU (Invitrogen, Carlsbad, CA,
USA) in complete media (Invitrogen, Carlsbad, CA, USA) for 8 h
on sequential days. BrdU positive cells and sytox stained nuclei
were visualised as described above, counted manually and the
ratio of BrdU/sytox stained cells used to calculate the number of
cells proliferating each day during an 8 h window. Cells were
counted from 3 fields of view (0.56 mm2, 206magnification) from
3 separate cultures.
Quantitative real time PCR experiments
The following procedures were performed in order to comply
with the Minimum Information for Publication of Quantitative
Real-Time PCR experiments MIQE guidelines [43].
RNA extraction and cDNA synthesis
RNA was immediately extracted from duplicate wells of 3
separate cell cultures. RNA extraction and genomic DNA removal
was performed using a RNeasy plus kit (Qiagen Inc., Chatsworth,
CA, USA) as per manufacturer’s recommendations. RNA was
concentrated by ethanol precipitation and quantified using a
NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA). Only RNA with an A260/280 ratio
between 1.8 and 2.1 and an A260/230 above 2.0 was used for
cDNA synthesis. For samples where enough RNA was obtained
(excludes day 2), the integrity of the RNA was confirmed by gel
electrophoresis. Residual genomic DNA was removed using the
genomic DNA wipeout buffer included in the Quantitect reverse
transcription kit (Qiagen Inc., Chatsworth, CA, USA). 800 ng of
RNA was reverse transcribed into cDNA for 30 min at 42uC using
a Quantitect reverse transcription kit (Qiagen Inc., Chatsworth,
CA, USA) as per manufacturer’s recommendations. To check for
contaminating genomic DNA, a control reaction was performed
which lacked the reverse transcriptase enzyme (–RT).
Quantitative PCR
qPCR was performed using a Stratagene MX3005P QPCR
system (Stratagene, La Jolla, CA, USA) with Brilliant II SYBR
(Stratagene, La Jolla, CA, USA). Each qPCR reaction mixture
contained 7.5 ml 2 x Brilliant II SYBR green master mix (Surestart
Taq DNA polymerase, 2.5 mM MgCl2, 6 ml cDNA), cDNA (80-
fold dilution, 20-fold for IGF-I), 500 nM each primer and RNase
free water to a final volume of 15 ml. Amplification was performed
in duplicate in 96 well plates (Stratagene, La Jolla, CA, USA) with
the following thermal cycling conditions: initial activation 95uC for
10 minutes, followed by 40 cycles of 15 s at 95uC, 30 s at 60uC,
and 30 s at 72uC. Control reactions included a no template
control (NTC) and -RT. Dissociation analysis of the PCR products
was performed by running a gradient from 60 to 95uC to confirm
the presence of a single PCR product. Products were also
sequenced to confirm identity. A dilution series made from known
concentrations of plasmid containing the PCR inserts was used to
calculate absolute copy numbers for each of the genes examined.
Standards for calculating absolute copy number for each gene
were prepared by cloning the PCR product from each primer pair
into a T/A pCR4-TOPO vector (Invitrogen, Carlsbad, CA, USA)
and transformation of chemically competent TOP10 Escherichia coli
cells (Invitrogen,. Carlsbad, CA, USA). Individual colonies were
grown and plasmids purified using a Fastprep plasmid purification
kit (Eppendorf, Hamburg, Germany). The concentration of each
plasmid was calculated based on absorbance at 260 nm, and a
dilution series produced for calculation of copy number via qPCR.
For relative quantification of IGF receptor paralogues, the PCR
efficiencies were calculated from a dilution series (1/20, 1/40, 1/
80, 1/160, 1/320, 1/640) of pooled cDNA samples.
Primer design
Many of the primers used for qPCR have previously been
described [40] and are listed in table 1. Primers were designed
using NetPrimer (Premier BioSoft) to have Tm of 60uC, and where
possible, to cross an exon-exon junction to avoid amplification of
genomic DNA. To determine exon-intron junction sites, genomic
sequences for orthologous genes from Danio rerio, Gasterosteus
aculeatus, Oryzias latipes, Takifugu rubripes and Tetraodon nigroviridis
were retrieved from Ensembl (http://ensembl.org/), and com-
pared to the Salmo salar cDNA sequences using the Spidey software
tool (http://www.ncbi.nlm.nih.gov/spidey/). Primers were used at
a final concentration of 500 nM.
Data analysis
The stability of reference genes for Atlantic salmon myogenic
cell culture has been previously described [44]. Data were
analysed using geNorm [45] using the geometric average of
Elongation factor 1 alpha (EF1-a), hypoxanthine phosphoribosyl
transferase 1 (Hprt1) and peptidyl prolyl isomerase A (Ppia) with the
normalised gene expression values displayed as arbitrary units
(A.U.). Input data for geNorm was absolute values derived from a
plasmid standard curve. Melting temperatures, efficiency values
and r2 values for standard curves are given in table 1. Relative
expression levels of IGF-IR paralogues were calculated with Ppia as
reference gene using the Q-gene software [46]. Ribosomal protein
S29 (Rps29) and ribosomal protein L13 (Rpl13) were the most
stable genes in starved and treated cells and so the geometric
average of these two genes were used for normalisation of starved
and treated cells gene expression data. Statistical analysis was
performed with Minitab (Minitab Inc). When data conformed to
parametric assumptions, ANOVA using Fisher’s individual error
post hoc test was used to identify significant differences. When
parametric assumptions were not met, Kruscal Wallis test was
used. Correlations in gene expression were calculated using
Pearson’s correlation, and when data where not normally
distributed, by Spearman rank correlation. Differences in gene
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expression are indicated by different letters on the graphs.
Hierarchical clustering analysis of gene expression data was
performed using Permutmatrix [47].
Results
Myogenic cell culture
Cell cultures were visualised using confocal microscopy and the
phenotype of cells determined at 2 d, 5 d, 8 d, 11 d and 14 d
(Fig. 1). The myogenic nature of the cell culture was confirmed by
the presence of multi-nucleated myotubes visualised by nuclei
stained with sytox green (Fig. 1A a,e,i,m,q), Alexa Fluor 568-
phalloidin stained actin filaments (Fig. 1A b, f, j, n, r) and the
presence of the myogenic marker desmin (Fig. 1A c,g,k,o,s). At 2 d,
all cells were mononucleic (Fig. 1a–d), which then fused to form
small myotubes at 5 d (Fig. 1A e–h) and 8 d (Fig. 1A i–l) and then
as the culture progressed, longer myotubes (Fig. 1m–p) and sheets
of longer multi-nucleated myotubes at 14 d (Fig. 1A q–t).
Cell proliferation
Initially, cells proliferated at a rate of 15%60.32% d21 (n = 9
Mean 6 S.E.), which then increased linearly from days 3 to 6
(r2 = 0.99), reaching 66%66.86% d21 (n = 9 Mean 6 S.E.)
(Fig. 1B). Proliferation rates remained at a constant level until 8
d, after which cells continued to proliferate, but accurate
measurement became impractical.
Expression of IGF-I, IGF-II and FGF2 and IGF receptors
IGF-I expression increased to a peak at 5 d of culture and then
decreased by 14 d to a level 15-fold less than at 5 d (Fig. 2A). IGF-
II expression was highest at 2 d in mononuclear cells and was then
downregulated before reaching a steady state expression at 14 d, 5-
fold lower than peak levels (Fig. 2B). Fibroblast growth factor 2
(FGF2) expression showed relatively high expression until 8 d of
culture, but then, like IGF-I and II, declined as the culture matured
(P,0.05) (Fig. 2C).
The two paralogues for IGF-IRA had distinct expression
patterns. IGF-IRa expression increased during maturation of the
culture showing peak values at 8 d and 14 d (P,0.05, Fig. 2D). In
contrast, IGF-IRb expression was high until 8 d and then decreased
2.3-fold at 17 d (P,0.05, Fig 2E). IGF-IRa mRNA levels were on
average 100 times more abundant than that of IGF-IRb
(P,0.001, data not shown). IGF2R mRNA increased during
maturation of the culture with peak levels at 14 d (P,0.01, Fig. 2F).
Expression of IGFBPs
The mRNA levels for IGFBPs 1 and 2.1 were below the limits of
detection using qPCR. IGFBP-2.2 expression was highest at 2 d
corresponding to mononuclear cells, decreased 4-fold at 14d
before increasing again in the later stages of the culture when
syncytial sheets of myotubes had formed (P,0.05, Fig. 3A).
IGFBP-4 was present at relatively low levels at the early (2d) and
late (17, 20 d) stages with a distinct 8-fold increase in expression at
8d (P,0.001, Fig. 3B). Expression of IGFBP-5.1 (Fig. 3C), IGFBP-
5.2 (Fig. 3D) and IGFBP-6 (Fig. 3E) were high in mononuclear
cells (2d) then declined as the culture matured and the proportion
of differentiated myotubes increased (P,0.01). Insulin like growth
factor binding protein-related protein-1 (IGFBP-rP1) showed peaks of
expression at days 2 and 8 of the culture (Fig. 3F).
Gene expression in starved cells
Only two of the genes studied showed altered expression in cells
deprived of amino acids and serum. IGF-I mRNA decreased
significantly in starved cells within 12 h (P,0.05, 5-fold down-
regulation) and to levels more than 10-fold lower than in control
cells by 72 h (P,0.05, Fig 4A). Steadily increasing expression of
Table 1. qPCR primer sequences, PCR efficiencies, correlation coefficients of standard curves, amplicon size and melting
temperature.
Gene Forward and Reverse primer (59-39) E (%) r2 size (bp) Tm u C Accession number
EF1a F: GAATCGGCTATGCCTGGTGAC R: GGATGATGACCTGAGCGGTG 96.0 0.998 141 86.0 BG933853
Ppia F: CATCCCAGGTTTCATGTGC R: CCGTTCAGCCAGTCAGTGTT 96.4 0.998 203 85.9 DY727143
Hprt1 F: CCGCCTCAAGAGCTACTGTAAT R: GTCTGGAACCTCAAACCCTATG 92.1 0.996 255 81.8 EG866745
FGF2 F: ATAAGCTTCAACTCCAGGCGACC R: AGCATTCATCTGTTGTCCGTCTC 102.1 0.990 230 81.7 GE794494
IGF-I F: CCTGTTCGCTAAATCTCACTTC R: TACAGCACATCGCACTCTTGA 102 0.995 226 81.7 EF432852
IGF-II F: GAAAACACAAGAATGAAGGTCAA R: CCACCAGCTCTCCTCCACATA 94.0 0.996 127 82.7 EF432854
IGF-IRa F: GGGGCTCTCCTTCTGTCCTA R: AGAGATAGACGACGCCTCCTA 97.2 0.995 175 85.9 EU861008
IGF-IRb F: CTAAATCTGTAGGAGACCTGGAG R: GGTTAGCCACGCCAAATAGATCC 100.0 0.996 138 86.3 EU861006
IGF2R F: CTTCATCCACGCTCAGCAG R: ACCCTGGGCCGTGTCTAC 96.0 0.998 168 84.3 CX325971
IGFBP-1 F: AGGACCAGGGACAAGAGGAAG R: CTGTTCCACCAGTTTCTTGC 98.2 0.995 154 82.3 EF432856
IGFBP-2.1 F: CGGTGAGGAAGGCCACTAAGG R: ATATCACAGTTGGGGATGT 95.0 0.998 249 85.3 EF432858
IGFBP-2.2 F: TTCCATGATAACAGGGGACCAG R: GACCGTGGGTGGACATGTGG 94.7 0.994 108 79.6 EF432860
IGFBP-4 F: ACTTCCATGCCAAGCAGTGC R: GGTCCCATCCTCACTCTCTC 95.6 0.993 164 87.5 EU861007
IGFBP-5.1 F: ATCACGGAGGACCAACTGC R: TGCTTGTCAATGGGTAGTGG 101.0 0.997 169 86.4 EF432862
IGFBP-5.2 F: TTCTCCAGAGGAAGCTATGTTAG R: TCAAGGCTGCTGACAGAGTG 96.7 0.996 170 86.3 EU861009
IGFBP-6 F: GCTGCGTGCCTCTTCCTCA R: TTACGGCAGGGTGCCTTTTC 101.0 0.998 159 86.1 EF432864
IGFBP-rP1 F: GAAGTGTGTGGCTCCGATG R: GTTTTCCGCTGGTGACCTTCT 103.2 0.997 249 84.8 EF432866
Rps29 F: GGGTCATCAGCAGCTCTATTGG R: AGTCCAGCTTAACAAAGCCGATG 96.1 0.998 167 84.7 NM_001139600
Rpl13 F: CGCTCCAAGCTCATCCTCTTCCC R: CCATCTTGAGTTCCTCCTCAGTGC 98.9 0.998 79 81.8 BT043698
doi:10.1371/journal.pone.0011100.t001
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IGFBP-rP1 was observed in starved cells, reaching levels 2.5-fold
higher than in control cells (P,0.05, Fig. 4B).
Gene expression in starved cells treated with amino acids
and IGF-I and II
Addition of amino acids to starved cells resulted in a 10-fold
increase in IGF-I expression within 6 h (p,0.01), although this
peak level of expression had fallen by 12 h (Fig. 5A). Treatment
with IGF-I and IGF-II alone stimulated IGF-I mRNA expression
at 3 and 6 h, however, the increase was only 2.5-3.5-fold and not
statistically significant. IGF-I combined with amino acids leads to a
synergistic response as an 18-fold increase was observed after 6 h
when both stimuli were present (P,0.01, Fig. 5A). IGF-II mRNA
increased 2 to 3-fold at 3-6 h in response to amino acid stimulus
(P,0.05), but did not respond to IGFs (Fig. 5B).
Amino acid stimulation resulted in increased expression of
IGFBP-4 6 h following treatment (P,0.05, Fig. 5C), but only when
amino acids and IGFs or insulin were the combined stimulus. The
two IGFBP-5 paralogues increased in response to amino acid
stimulation after 6 h (P,0.05), and were still elevated at 24 h
(Figs. 5D and 5E). Expression of both paralogues did not change in
the presence of IGF-I or IGF-II alone, however both paralogues
increased expression with amino acid addition. Interestingly, for
IGFBP-5.2, a synergistic effect was observed after 24 h when IGF-
I, IGF-II or insulin were added in the presence of amino acids
(P,0.01, Fig. 5E). Expression was increased from 2-fold for amino
acid stimulation alone, up to 5-fold when amino acids were
combined with either hormone. IGFBP-6 was unique in being the
only IGFBP to respond to IGF-I or IGF-II alone, with increased
expression observed 12 h following stimulation (p,0.05, Fig. 5F).
IGFBP-6 mRNA levels remained unchanged in the presence of
amino acids.
Expression of IGFBP-2.1 and 2.2 was below the limits of
detection. For the remaining genes examined (FGF2, IGF-IRa,
IGF-IRb, IGF2R, IGFBP-rP1) there were no significant changes in
gene expression with the treatments.
Expression relative to myogenic regulatory factors
We have previously examined the expression of the myogenic
regulatory factors (MRFs) myoD1a, 1b, 1c, myog, Myf5 and MRF4,
MEF2A and a marker of myogenic progenitor cells (Pax7) using the
same cultures [48]. To place the components of the IGF signalling
pathway into a myogenic framework, we clustered their expression
during myotube maturation with those of the MRFs, MEF2A and
Pax7. A summary heat map and hierarchical clustering of gene
expression patterns during the maturation of the culture is shown
in Fig. 6.
A number of genes showed highly correlated expression patterns
suggesting that they may be regulated by similar pathways. These
included myoD1b and IGFBP-4 (R= 0.88, P,0.0001, Fig. S1A),
IGFBP-4 and myf5 (R= 0.84, P,0.0001 Fig. S1B) and IGF-II and
IGFBP-rP1 (R= 0.81, P,0.0001 Fig. S1C). Correlated patterns of
gene expression patterns were observed in the individual cultures
as well as in the overall analysis, demonstrating that the
correlations are not an artefact of combining the data from three
cultures.
Discussion
Distinct phases of gene expression are apparent associated with
mono-nucleic cells, the initial cell proliferation phase and terminal
differentiation and myotube formation (Figs. 1A, 1B & 6). Cluster I
comprised genes predominantly expressed in mono-nucleated cells
and included IGFBP-5.1 and 5.2, IGFBP-6, IGFBP-rP1, IGFBP-2.2,
MRF4 and IGF-II. Cluster II comprised myoD1b and 1c, myf5, pax7,
IGF-I, FGF2 and IGF-IRb, and had highest expression during the
initial phase of cell proliferation. Cluster III contained genes that
were predominantly expressed in differentiated cells and was
comprised of MEF2A, IGF2R, myog, myoD1a and IGF-IRa.
Expression of IGF-I (Fig. 2A) and IGF-II (Fig. 2B) was higher at
2-8 d, than at 14-20 d when multinucleated myotubes predom-
inated (Fig. 1A). This high expression at early time points may be
necessary to start cell proliferation and for quiescent cells to enter
the cell cycle. There was a transient increase in IGF-II expression
at 8 d (Fig. 2B), which coincides with the maximal expression of
myog (Fig. 6) and all three myoD paralogues (Fig. 6). In a NFB4
mutant muscle cell line, exogenous IGF-I and IGF-II induce
expression of myog, and myog over-expression increases differenti-
ation and IGF-II expression, showing IGF-II and myog can
regulate each others transcription [49]. MyoD overexpression in
CH3 10T1/2 cells induces IGF-II gene and protein expression as
early events in differentiation, leading to activation of the IGF-I
receptor and down stream signalling molecules such as AKT [50].
IGF-II is also known to be more potent in stimulating myogenesis
than IGF-I, whereas the actions of IGF-I have been shown to
delay differentiation [51].
During the early phase of cell culture, IGF-I signals through the
ERK1/2 MAPK pathway, then through AKT at later time points
[52]. The presence or absence of other growth factors such as
basic fibroblast growth factor (bFGF), which can also signal via
ERK 1/2 MAPK pathway [53], may attenuate the effects of IGFs
[22] by inhibiting differentiation [19–21] and promoting myoblast
cell proliferation [22]. High expression of FGF2 (Fig. 2C)
coincided with high expression of IGF-I (Fig. 2A) at early stages
of the cell culture as cells began to proliferate (Fig. 1B), consistent
with a role in cell proliferation. As cells underwent differentiation,
indicated by the highest levels of myog expression at days 8–14
(Fig. 6), expression of FGF2 decreased (Fig. 2C).
IGF signalling requires the IGF hormones to bind to the IGF-I
receptors to initiate the signalling cascade that results in
phosphorylation of AKT/mTOR. In Atlantic salmon, two
paralogues of IGF-IR are found. IGF-IRa mRNA levels were on
average 100-fold more abundant than IGF-IRb, which recapitu-
lates their in vivo levels (Bower and Johnston, unpublished results).
The two paralogues were also differentially expressed relative to
each other (Fig. 2D and 2E), with IGFR1a mRNA levels
increasing while IGFR1b decreased. The differences in expression
suggest that the genes coding for the two receptors have acquired
distinct cis regulatory elements since they were duplicated. IGF-I
receptors in sea bream increase in number as myogenic cells
differentiate [52], which may be important in the switch from
MAPK to AKT signalling. Based on the expression we observed,
IGF-IRa is most likely to play this role in the differentiation of
Atlantic salmon myoblasts.
Figure 1. Atlantic salmon myogenic cell culture phenotype and cell proliferation rates. (A) Growth and differentiation of myogenic cells
extracted from S salar fast myotomal muscle at 2 d (a–d), 5 d (e–h), 8 d (i–l), 11 d (m–p) and 14 d (q–t). Nuclei stained with sytox green (a,e,i,m,q) and
actin counterstained with phalloidin (b,f,j,n,r) confirmed the presence of multinucleated myotubes. Myogenic cells were also identified by positive
desmin staining (c,g,k,o,s). The combined images are shown in the overlay (d,h,l,p,t). Scale bars represent 50 mm. (B) Proliferation rate of cultured
myogenic cells calculated as the proportion of BrdU positive nuclei to sytox green stained nuclei following an 8 h exposure to BrdU (mean 6 S.E.
n = 9).
doi:10.1371/journal.pone.0011100.g001
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Expression of IGF2R increased throughout the culture, with
highest levels observed in differentiated cells (Fig. 2F). The IGF2R
has been demonstrated to target IGF-II for degradation via the
lysosomal pathway [54]. However, recent findings suggest that the
IGF2R may trigger a signalling cascade leading to cardiac muscle
cell hypertrophy [55], the regulation of cell invasion and cell
Figure 2. Gene expression profiles for IGF-I, IGF-II, FGF2, PCNA, IGFR1a, IGFR1b and IGF2R during myotube maturation. Expression profiles
for IGF-I (A), IGF-II (B), FGF2 (C), PCNA (D), IGF-IRa (E), IGF-IRb (F) and IGF2R (G) in Atlantic salmon myogenic cell culture at 2 d, 5 d, 8 d, 11 d, 14 d, 17 d
and 20 d. Values represent mean 6 S.E., 6 samples per point from three cultures. Significant differences between means are indicated by different
letters.
doi:10.1371/journal.pone.0011100.g002
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motility in human cancer cells [56,57] and the binding of multiple
ligands other than IGF-II [58,59].
IGFBP-2.2 expression was down regulated from 2 d onwards
(Fig. 3A), consistent with IGFBP-2 being a negative regulator of
growth [18]. IGFBP-4 has recently been shown to be a negative
regulator of growth when overexpressed in zebrafish embryos [60].
We found IGFBP-4 expression peaked at 8 d (Fig. 3B), coinciding
with maximal myog expression (Fig. 6), with values 7-fold higher
Figure 3. Gene expression profiles for IGFBPs during myotube maturation. Expression profiles for IGFBP-2.1 (A), IGFBP-4 (B), IGFBP-5.1 (C),
IGFBP-5.2 (D), IGFBP-6 (E) and IGFBP-rP1 (F) in Atlantic salmon myogenic cell culture at 2 d, 5 d, 8 d, 11 d, 14 d, 17 d and 20 d. Values represent mean6
S.E., 6 samples per point from three cultures. Significant differences between means are indicated by different letters.
doi:10.1371/journal.pone.0011100.g003
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than in mono nuclear myoblasts, before declining at later stages of
the culture (Fig. 3B). Interestingly, expression of IGFBP-4 was highly
correlated with myoD1bR=0.88, p,0.0001, Fig. 6, Fig. S1A) and
also myf5 (R= 0.84, p,0.0001, Fig. 6, Fig. S1B) and thus may share
common cis regulatory elements with these MRFs. We have
previously reported that IGFBP-4 was the only IGFBP constitutively
upregulated in response to refeeding in Atlantic salmon in vivo [40],
which combined with the expression pattern reported here, suggests
that IGFBP-4 is a promyogenic factor in Atlantic salmon.
Differentiation of C2C12 muscle cells is promoted by IGFBP-5
[61] and expression increases during differentiation of C2
myoblast cell line [62]. In contrast to these findings in mouse
cell lines, we found expression of both IGFBP-5 paralogues
significantly decreased from 2 d, reaching minimal expression
levels by 5 d for IGFBP-5.1 (Fig. 3C) and 8 d for IGFBP-5.2
(Fig. 3D). We have previously reported an increase in IGFBP-5
expression as an early response to feeding, similar to findings in
rainbow trout [63]. From these results, a plausible hypothesis
would be that IGFBP-5 plays a role in stimulating MPCs to enter
the cell cycle in Atlantic salmon.
Cell proliferation has been shown to be inhibited by IGFBP-6 in
many mammalian cell types [64]. Furthermore, IGFBP-6 inhibits
growth in zebrafish embryos [41]. Consistent with these findings,
expression of IGFBP-6 significantly decreased (Fig. 3E) as cell
proliferation increased (Fig. 1B). Mammalian IGFBP-6 has a 10–
100 fold higher affinity for IGF-II than IGF-I [65], so we suggest
that downregulation of IGFBP-6 may increase the availability of
IGF-II to other binding proteins required for differentiation.
Stimulation of gene expression by amino acids and IGFs
IGF-I mRNA expression is modulated by nutrition in a number
of fish species [40,63,66]. Consistent with these findings, we
observed decreased IGF-I expression within 12 h of amino acid
and serum withdrawal, by as much as 10-fold after 72 h (Fig. 4A).
This reduction in IGF-I mRNA levels was rapidly reversed by
addition of amino acids, with expression increasing 3- and 9-fold
after 3 and 6 h respectively (Fig. 5A). Amino acids and IGFs had a
synergistic effect on IGF-I expression, suggesting that separate
signalling pathways have been activated, or that different
components of the same pathway are responsive to amino acids
and IGFs. It is very interesting that we observed an increase in
IGF-I mRNA expression by IGF-I stimulation, as IGF-I
downregulates IGF-I mRNA in C2C12 myoblasts [67]. Para-
crine/autocrine production of IGF-I appears to be more
important than circulating levels in stimulating muscle growth
[68–71]. It is therefore possible that IGF-I mRNA expression
stimulated by IGF-I peptide in teleosts could be an important
factor in the indeterminate growth of teleosts in comparison to
mammals. The transcriptional activation of IGF-I by amino acids
also suggests that local IGF-I production in fast muscle can occur
independently of growth hormone, insulin and IGFs. Amino acid
availability, and in particular, the essential amino acid leucine is
required for activation of mTORC1 in mammals [23,24]. Amino
acid stimulation could occur through an amino acid sensing
signalling pathway regulated by either vps34 (a class 3 PI3K) [26],
recombination activating proteins (Rags) [27,28] or the ste-20
related mitogen-activated protein kinase kinase kinase kinase 3
(MAP4K3) [29] leading to activation of mTORC1 [72].
Although IGF-II mRNA expression did not change by amino
acid and serum withdrawal, mRNA levels increased specifically in
response to amino acids, similar to mammals [73]. We have
recently shown that amino acid and serum starvation of Atlantic
salmon myogenic cells results in cells withdrawing from the cell
cycle and entering a quiescent state [48] and that upon stimulation
by amino acids they enter the cell cycle. The observed increase in
IGF-II mRNA at 3 and 6 h suggests that increased expression may
be necessary for cells to enter the cell cycle. This is consistent with
the high expression observed at 2 to 8 d in the cell culture (Fig. 2B).
Amino acids alone were able to stimulate the expression of both
IGFBP-5 paralogues (Fig. 5D and 5E) and a synergistic effect was
observed for IGFBP-5.2 expression when IGFs or insulin were also
present. This suggests that two separate pathways need to be
stimulated to achieve maximum transcriptional activity, similar to
the synergism between amino acids and insulin in phosphorylation
of S6K1 in trout [74]. Interestingly, the synergistic effect was
observed for all three hormones, suggesting that signalling occurs
through insulin receptor substrate-1 (IRS-1), which is a common
substrate for both IGF-I and insulin receptors, leading to
activation of AKT/mTOR pathway [75]. Signaling through
IRS-1 and the PI3K/AKT/mTOR pathway regulates IGF-I
induced IGFBP-5 expression in smooth muscle cells [76] and
could converge with the amino acid signaling pathway on
mTORC1, where recently, phosphorylation of S1261 has been
demonstrated to occur through insulin signaling in an amino acid
Figure 4. Gene expression profiles during serum deprivation.
Expression profiles of IGF-I (A) and IGFBP-rP1 (B) in 9 d myogenic cells in
complete media (closed circle) or amino acid and serum deprived
media (open circle). For ease of interpretation, values at time 0 h were
transformed so that the mean value is equal to 1. Values represent
mean 6 S.E., 3 independent cell cultures. Significant differences in
expression are indicated by an asterisk (* P,0.05, ** P,0.01).
doi:10.1371/journal.pone.0011100.g004
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dependent manner [23]. The lack of a synergistic response for
IGFBP-5.1 suggests that the promoters of the two paralogues
contain different cis regulatory elements responsible for their
different expression responses. The synergistic effect of IGFs and
amino acids on IGFBP-5.2 expression could explain the differences
in gene expression observed in Atlantic salmon fed to satiation
after a period of reduced feed intake, where only IGFBP-5.2
showed a positive transcriptional response [40]. The expression
profile of both IGFBP-5 paralogues was temporally distinct to the
IGFs and other binding proteins, with upregulation by amino
acids combined with IGFs only seen at 12 and 24 h post
stimulation. This suggests that IGFBP-5 lies further downstream in
the signalling pathway and needs other cofactors to be activated
other than those stimulated directly by amino acids and IGFs.
IGFBP-4 showed a more restricted expression pattern, and was
only increased when amino acids were present with IGFs or
insulin (Fig. 5C). The requirement of both stimuli to be present for
increased expression, combined with the peak expression coincid-
ing with maximal myog expression in developing myotubes (Figs. 1
and 3B) suggests an important role for IGFBP-4 in both nutritional
and myogenic processes.
IGFBP-6 was unique amongst the binding proteins in being
stimulated by IGFs alone, and the increased expression appears to
be inhibited by the presence of amino acids (Fig. 5F). As IGFBP-6
has been considered a negative regulator of cell proliferation [64],
a plausible hypothesis based on the observed expression pattern is
that after ingested amino acids have been metabolised and become
depleted, IGFBP-6 expression is increased, due to the presence of
locally produced IGF-I and II, and its translational product
sequesters available IGFs, thereby inhibiting any positive feedback
mechanisms. This could be a mechanism to tightly control the
availability of IGF-II, as IGF-II expression was only increased by
amino acids (Fig. 5B).
It is striking that we observe distinct temporal patterns of
expression for each of the binding proteins within a 24 h period
upon stimulation by the various treatments. This could have
important implications for many studies examining the function
of the IGFBPs. For example, overexpression of IGFBPs is a
technique often used in functional analysis, as is the administra-
tion of recombinant protein using in vitro cell culture techniques.
These methodologies lead to the constitutive presence of the
protein, and therefore could result in misleading information
being obtained about the functional role of the IGFBPs in growth
and development, if, as our data suggests, they have discrete
temporal expression patterns. The results described herein
highlight the complexities in the regulation of Atlantic salmon
IGFBPs.
In conclusion, we have found that amino acids and IGFs
separately and together can stimulate the expression of many
genes in the IGF signalling pathway. Figure 7 summarises a model
of the transcriptional regulation of myogenesis by amino acids and
IGFs based on our results. These results highlight the importance
of amino acids in regulating myogenesis in Atlantic salmon and
demonstrate that amino acids alone are capable of stimulating
autocrine/paracrine production of IGFs. The identification of
markers specific for amino acid, IGF and synergistic responses will
Figure 5. Analysis of stimulation of the IGF-signaling pathway by amino acids and IGFs. Expression profiles for IGF-I (A), IGF-II (B), IGFBP-4
(C), IGFBP-5.1 (D), IGFBP-5.2 (E) and IGFBP-6 (F) in day 9 myogenic cells starved for 72 h, then treated with various combinations of amino acids, IGFs
and insulin or starve media (starve media = no amino acid or serum). cDNA was synthesised from RNA extracted 0, (black bar) 3 (diagonal stripe), 6
(horizontal stripe), 12 (white bar) and 24 h (sigmoidal stripe) following treatment. For ease of interpretation of the cell treatments, the 72 h starved
cell values were transformed so that the mean value is equal to 1. Values represent mean 6 S.E., 3 independent cell cultures. Changes in expression
were considered significant if they were different to both the 72 h starved value and the control treatment. Significant differences in expression are
indicated by an asterisk (* P,0.05, ** P,0.01).
doi:10.1371/journal.pone.0011100.g005
Figure 6. Heat map summary and hierarchical clustering of gene expression. Heat map summary and hierarchical clustering for MRFs,
MEF2A, pax7, FGF2 and components of the IGF signaling pathway during Atlantic salmon myogenic cell culture at 2 d, 5 d, 8 d, 11 d, 14 d, 17 d and 20
d. Rows are standardized to have mean 0 and standard deviation 1 so that red indicates high and green indicates low values.
doi:10.1371/journal.pone.0011100.g006
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be useful tools for future studies aimed at unravelling the signalling
events controlling teleost myogenesis.
Supporting Information
Figure S1 Correlated gene expression patterns in 3 separate
cultures for myoD1b and IGFBP-4 (R= 0.88, P,0.0001, Sup Fig.
S1A), IGFBP-4 and myf5 (R= 0.84, P,0.0001 Sup Fig. S1B) and
IGF-II and IGFBP-rP1 (R=0.81, P,0.0001 Sup Fig. S1C).To
demonstrate that the correlations are not due to inter-culture
variation, the data points for culture 1, 2 and 3 are indicated
separately by square, triangle and circle respectively. The
combined regression (using data points from all cultures N= 42)
is shown.
Found at: doi:10.1371/journal.pone.0011100.s001 (0.28 MB TIF)
Acknowledgments
All S. salar samples were provided by Landcatch, Lochgilphead, UK. The
authors thank Dr Daniel Garcia de la serrana Castillo and Dr Daniel
Macqueen for critically reading the manuscript and Mr Luke Bower for
help with fish maintenance.
Author Contributions
Conceived and designed the experiments: NIB IAJ. Performed the
experiments: NIB. Analyzed the data: NIB. Wrote the paper: NIB IAJ.
References
1. Stewart CEH, Rotwein P (1996) Growth, differentiation, and survival: Multiple
physiological functions for insulin-like growth factors. Physiol Rev 76: 1005–1026.
2. LeRoith D, Bondy C, Yakar S, Liu J, Butler A (2001) The somatemedin
hypothesis: 2001. Endocr Rev 22: 53–74.
Figure 7. A proposed model of autocrine/paracrine IGF signaling in Atlantic salmon muscle. The model shows amino acid and IGF
stimulation of transcription leading to the activation of the myogenic program in Atlantic salmon. It should be noted that we have not measured
protein levels, protein activity or protein phosphorylation, so unconfirmed target proteins are indicated by a question mark. Amino acids stimulate
IGFBP-5.1, IGFBP-5.2, IGF-I and II expression, which, when translated and secreted from the cell, are able to stimulate the PI3K/AKT/mTOR pathway
leading to a positive feedback loop resulting in the synergistically enhanced expression of IGF-I, IGFBP-5.2 and IGFBP-4. When amino acids are absent,
endocrine and paracrine production of IGF-I and II stimulate IGFBP-6, which could serve as a mechanism to sequester available IGFs and thereby
inhibit any positive feedback loops.
doi:10.1371/journal.pone.0011100.g007
IGF Pathway in Salmon Muscle
PLoS ONE | www.plosone.org 12 June 2010 | Volume 5 | Issue 6 | e11100
3. Adams GR (2006) Satellite cell proliferation and skeletal muscle hypertrophy.
App Physiol Nutr Metab 31: 782–790.
4. Dhawan, Rando (2005) Stem cells in postnatal myogenesis: molecular
mechanisms of satellite cell quiescence, activation and replenishment. Trends
Cell Biol 15: 666–673.
5. Engert JC, Berglund EB, Rosenthal N (1996) Proliferation precedes differen-
tiation in IGF-I-stimulated myogenesis. J Cell Biol 135: 431–440.
6. Jones JI, Clemmons DR (1995) Insulin-Like Growth-Factors and Their Binding-
Proteins - Biological Actions. Endocr Rev 16: 3–34.
7. Duan C, Bauchat JR, Hsieh T (2000) Phosphatidylinositol 3-kinase is required
for insulin-like growth Factor-I-Induced vascular smooth muscle cell prolifer-
ation and migration. Circ Res 86: 15–23.
8. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR (1997) The
mitogenic and myogenic actions of insulin-like growth factors utilize distinct
signaling pathways. J Biol Chem 272: 6653–6662.
9. Yamaguchi A, Fujikawa T, Shimada S, Kanbayashi I, Tateoka M, et al. (2006)
Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory
overload in hypophysectomized rats. Pflugers Arch 453: 203–210.
10. Clemmons DR (2001) Use of mutagenesis to probe IGF-binding protein
structure/function relationships. Endocr Rev 22: 800–817.
11. Duan C (2002) Specifying the cellular responses to IGF signals: roles of IGF-
binding proteins. J Endocrinol 175: 41–54.
12. Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor
binding proteins. Endocr Rev 23: 824–854.
13. Clemmons DR (1998) Role of insulin-like growth factor binding proteins in
controlling IGF actions. Mol Cell Endocrinol 140: 19–24.
14. Jones JI, Gockerman A, Busby WH, Camachohubner C, Clemmons DR (1993)
Extracellular-Matrix Contains Insulin-Like Growth-Factor Binding Protein-5 -
Potentiation of the Effects of Igf-I. J Cell Biol 121: 679–687.
15. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR (1993) Insulin-
Like Growth-Factor Binding Protein-1 Stimulates Cell-Migration and Binds to
the Alpha-5-Beta-1 Integrin by Means of Its Arg-Gly-Asp Sequence. Proc Natl
Acad Sci USA 90: 10553–10557.
16. Smith CKI, Janney MJ, Allen RE (1994) Temporal expression of myogenic
regulatory genes during activation, proliferation, and differentiation of rat
skeletal muscle satellite cells. J Cell Physiol 159: 379–385.
17. Ren HX, Yin P, Duan CM (2008) IGFBP-5 regulates muscle cell differentiation
by binding to IGF-II and switching on the IGF-II auto-regulation loop. J Cell
Biol 182: 979–991.
18. Duan CM, Ding J, Li Q, Tsai W, Pozios K (1999) Insulin-like growth factor
binding protein 2 is a growth inhibitory protein conserved in zebrafish. Proc Natl
Acad Sci U S A 96: 15274–15279.
19. Clegg CH, Linkhart TA, Olwin BB, Hauschka SD (1987) Growth-Factor
Control of Skeletal-Muscle Differentiation - Commitment to Terminal
Differentiation Occurs in G1 Phase and Is Repressed by Fibroblast Growth-
Factor. J Cell Biol 105: 949–956.
20. Spizz G, Roman D, Strauss A, Olson EN (1986) Serum and Fibroblast Growth-
Factor Inhibit Myogenic Differentiation through a Mechanism Dependent on
Protein-Synthesis and Independent of Cell-Proliferation. J Biol Chem 261:
9483–9488.
21. Weyman CM, Wolfman A (1998) Mitogen-activated protein kinase kinase
(MEK) activity is required for inhibition of skeletal muscle differentiation by
insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 139:
1794–1800.
22. Layne MD, Farmer SR (1999) Tumor necrosis factor-alpha and basic fibroblast
growth factor differentially inhibit the insulin-like growth factor-I induced
expression of myogenin in C2C12 myoblasts. Exp Cell Res 249: 177–187.
23. Acosta-Jaquez HA, Keller JA, Foster KG, Ekim B, Soliman GA, et al. (2009)
Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling
and Cell Growth. Mol Cell Biol 29: 4308–4324.
24. Atherton PJ, Smith K, Etheridge T, Rankin D, Rennie MJ (2009) Distinct
anabolic signaling responses to amino acids in C2C12 skeletal muscle cells.
Amino acids DOI:10.1007/s00726-009-0377-x.
25. Nicklin P, Bergman P, Zhang BL, Triantafellow E, Wang H, et al. (2009)
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy. Cell
136: 521–534.
26. Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, et al. (2005) Amino
acids mediate mTOR/raptor signaling through activation of class 3 phospha-
tidylinositol 30H-kinase. Proc Natl Acad Sci U S A 102: 14238–14243.
27. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, et al. (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.
Science 320: 1496–1501.
28. Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL (2008) Regulation of
TORC1 by Rag GTPases in nutrient response. Nature Cell Biology 10:
935–945.
29. Findlay GM, Yan L, Procter J, Mieulet V, Lamb RF (2007) A MAP4 kinase
related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem J
403: 13–20.
30. Johnston IA, Battram J (1993) Feeding energetics and metabolism in demersal
fish species from Antartctica, temperate and tropical environments.Mar Biol 115:
7–14.
31. Talbot C, Preston T, East BW (1986) Body-Composition of Atlantic Salmon
(Salmo-Salar L) Studied by Neutron-Activation Analysis. Comp Biochem
Physiol A Physiol 85: 445–450.
32. Bardonnet A, Bagliniere JL (2000) Freshwater habitat of Atlantic salmon (Salmo
salar). Can J Fish Aqua Sci 2000 57: 497–506.
33. Kadri S, Metcalfe NB, Huntingford FA, Thorpe JE (1995) What Controls the
Onset of Anorexia in Maturing Adult Female Atlantic Salmon. Funct Ecol 9:
790–797.
34. Amores A, Force A, Yan YL, Joly L, Amemiya C, et al. (1998) Zebrafish hox
clusters and vertebrate genome evolution. Science 282: 1711–1714.
35. Jaillon O, Aury JM, Brunet F, Petit JL, Stange-Thomann N, et al. (2004)
Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early
vertebrate proto-karyotype. Nature 431: 946–957.
36. Allendorf FW, Thogaard, GH (1984) Tetraploidy and evolution of salmonids
fishes. In: Turner BJ, ed. Evolutionary Genetics of Fishes. New York: Plenum.
pp 1–53.
37. Bailey GS, Poulter RTM, Stockwell PA (1978) Gene Duplication in Tetraploid
Fish - Model for Gene Silencing at Unlinked Duplicated Loci. Proc Natl Acad
Sci U S A 75: 5575–5579.
38. Macqueen DJ, Johnston IA (2008) Evolution of follistatin in teleosts revealed
through phylogenetic, genomic and expression analyses. Dev Genes Evol 218:
1–14.
39. Zhou J, Li W, Kamei H, Duan C (2008) Duplication of the IGFBP-2 gene in
teleost fish: Protein structure and functionality conservation and gene expression
divergence. PLoS ONE 3(12): e3926. doi:10.1371/journal.pone.0003926.
40. Bower NI, Li XJ, Taylor R, Johnston IA (2008) Switching to fast growth: the
insulin-like growth factor (IGF) system in skeletal muscle of Atlantic salmon.
J Exp Biol 211: 3859–3870.
41. Wang X, Lu L, Li Y, Li M, Chen C, et al. (2009) Molecular and functional
charcterisation of two distinct IGF binding protein-6 genes in zebrafish.
Am J Physiol Regul Integr Comp Physiol 296: R1348–1357.
42. Koumans JTM, Akster HA, Dulos GJ, Osse JWM (1990) Myosatellite Cells of
Cyprinus-Carpio (Teleostei) Invitro - Isolation, Recognition and Differentiation.
Cell Tissue Res 261: 173–181.
43. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE
Guidelines: Minimum Information for Publication of Quantitative Real-Time
PCR Experiments. Clin Chem 55: 611–622.
44. Bower NI, Johnston IA (2009) Selection of reference genes for expression studies
with fish myogenic cell cultures. BMC Mol Biol;DOI: 10.1186/1471-2199-10-
80.
45. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002)
Accurate normalization of real-time quantitative RT-PCR data by
geometric averaging of multiple internal control genes. Genome Biol. 3,
RESEARCH0034.
46. Muller PY, Janovjak H, Miserez AR, Dobbie Z (2002) Processing of gene
expression data generated by quantitative real-time RT-PCR. Biotechniques 32:
1372–1378.
47. Caraux G, Pinloche S (2005) PermutMatrix: a graphical environment to arrange
gene expression profiles in optimal linear order. Bioinformatics 21: 1280–1281.
48. Bower NI, Johnston IA (2010) Paralogues of Atlantic salmon myoblast
determination factor genes are distinctly regulated in proliferating and
differentiating myogenic cells. Am J Physiol Regul Integr Comp Physiol.
doi:10.1152/ajpregu.00114.2010.
49. Sarbassov DD, Stefanova R, Grigoriev VG, Peterson CA (1995) Role of Insulin-
Like Growth-Factors and Myogenin in the Altered Program of Proliferation and
ifferentiation in the Nfb4 Mutant Muscle-Cell Line. Proc Natl Acad Sci U S A
92: 10874–10878.
50. Wilson EM, Hsieh MM, Rotwein P (2003) Autocrine growth factor signaling by
insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation.
J Biol Chem 278: 41109–41113.
51. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR (1994) Igf-II is more
active than Igf-I in stimulating L6a1 myogenesis - greater mitogenic actions of
Igf-I delay differentiation. J Cell Physiol 161: 277–284.
52. Montseratt N, Sanchez-Gurmaches J, Garcia de la Serrana D, Navarro MI,
Gutierrez J (2007) IGF-I binding and receptor signal transduction in primary cell
culture of muscle cells of gilthead sea bream: changes throughout in vitro
development. Cell Tissue Res 330: 503–513.
53. Pintucci G, Moscatelli D, Saponara F, Biernacki PR, Baumann FG, et al. (2002)
Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells.
FASEB J 16: 598–600.
54. Boker C, vonFigura K, HilleRehfeld A (1997) The carboxy-terminal peptides of
46 kDa and 300 kDa mannose 6-phosphate receptors share partial sequence
homology and contain information for sorting in the early endosomal pathway.
J Cell Sci 110: 1023–1032.
55. Chu CH, Tzang BS, Chen LM, Kuo CH, Cheng YC, et al. (2008) IGF-II/
mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial
natriuretic peptide/BNP expression via G alpha q interaction and protein kinase
C-alpha/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol 197:
381–390.
56. Schiller HB, Szekeres A, Binder BR, Stockinger H, Leksa B (2008) Mannose 6-
Phosphate/Insulin-like Growth Factor 2 Receptor Limits Cell Invasion by
Controlling aVb3 Integrin Expression and Proteolytic Processing of Urokinase-
type Plasminogen Activator Receptor. Mol Biol Cell 20: 745–756.
57. Felding-Habermann B, O’Toole TE, Smith JW, Fransvea E, Ruggeri ZM, et al.
(2001) Integrin activation controls metastasis in human breast cancer. Proc Natl
Acad Sci USA 98: 1853–1858.
IGF Pathway in Salmon Muscle
PLoS ONE | www.plosone.org 13 June 2010 | Volume 5 | Issue 6 | e11100
58. Kang JX, Li YY, Leaf A (1997) Mannose-6-phosphate/insulin-like growth
factor-II receptor is a receptor for retinoic acid. Proc Natl Acad Sci U S A 94:
13671–13676.
59. Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, et al. (2000)
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor
for granzyme B during cytotoxic T cell-induced apoptosis. Cell 103: 491–500.
60. Li MY, Li Y, Lu L, Wang XL, Gong QL, et al. (2009) Structural, gene
expression, and functional analysis of the fugu (Takifugu rubripes) insulin-like
growth factor binding protein-4 gene. Am J Physiol Regul Integr Comp Physiol
296: R558–R566.
61. Ren HX, Yin P, Duan CM (2008) IGFBP-5 regulates muscle cell differentiation
by binding to IGF-II and switching on the IGF-II auto-regulation loop. J Cell
Biol 182: 979–991.
62. Rousse S, Montarras D, Pinset C, Dubois C (1998) Up-regulation of insulin-like
growth factor binding protein-5 is independent of muscle cell differentiation,
sensitive to rapamycin, but insensitive to wortmannin and LY294002.
Endocrinology 139: 1487–1493.
63. Gabillard JC, Kamangar BB, Montserrat N (2006) Coordinated regulation of
the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus
mykiss). J Endocrinol 191: 15–24.
64. Seurin D, Lassarre C, Blenvenu G, Babajko S (2002) Insulin-like growth factor
binding protein-6 inhibits neuroblastoma and cell proliferation and tumour
development. Eur J Cancer 38: 2058–2065.
65. Bach LA (2005) IGFBP-6 five years on; not so ‘forgotten’? Growth Horm IGF
Res 15: 185–192.
66. Chauvigne F, Gabillard JC, Weil C, Rescan PY (2003) Effect of refeeding on
IGFI, IGFII, IGF receptors, FGF2, FGF6, and myostatin mRNA expression in
rainbow trout myotomal muscle. Gen Comp Endocrinol 132: 209–215.
67. Frost RA, Nystrom GJ, Lang CH (2002) Regulation of IGF-I mRNA and signal
transducers and activators of transcription-3 and-5 (Stat-3 and-5) by GH in
C2C12 myoblasts. Endocrinology 143: 492–503.
68. Mathews LS, Hammer RE, Behringer RR, Dercole AJ, Bell GI, et al. (1988)
Growth Enhancement of Transgenic Mice Expressing Human Insulin-Like
Growth Factor-I. Endocrinology 123: 2827–2833.
69. Shavlakadze T, Boswell JM, Burt DW, Asante EA, Tomas FM, et al. (2006) Rsk
alpha-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and
blood: Impact on regeneration, denervation and muscular dystrophy. Growth
Horm IGF Res 16: 157–173.
70. Coleman ME, Demayo F, Yin KC, Lee HM, Geske R, et al. (1995) Myogenic
Vector Expression of Insulin-Like Growth-Factor-I Stimulates Muscle-Cell
Differentiation and Myofiber Hypertrophy in Transgenic Mice. J Biol Chem 27:
12109–12116.
71. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, et al. (2001)
Localized Igf-1 transgene expression sustains hypertrophy and regeneration in
senescent skeletal muscle. Nat Genet 27: 195–200.
72. Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, et al. (2000)
Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats
via a rapamycin-sensitive pathway. J Nutr 130: 2413–2419.
73. Erbay E, Park I, Nuzzi PD, Schoenherr CJ, Chen J (2003) IGF-II transcription
in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol 163:
931–936.
74. Seiliez I, Gabillard JC, Skiba-Cassy S, Garcia-Serrana D, Gutierrez J, et al.
(2008) An in vivo and in vitro assessment of TOR signaling cascade in rainbow
trout (Oncorhynchus mykiss). Am J Physiol Regul Integr Comp Physiol 295:
R329–R335.
75. Giorgetti S, Ballotti R, Kowalskichauvel A, Tartare S, Vanobberghen E (1993)
The Insulin and Insulin-Like Growth Factor-I Receptor Substrate Irs-1
Associates with and Activates Phosphatidylinositol 3-Kinase Invitro. J Biol
Chem 268: 7358–7364.
76. Duan CM, Liimatta MB, Bottum OL (1999) Insulin-like growth factor (IGF)-I
regulates IGF-binding protein-5 gene expression through the phosphatidylino-
sitol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway. J Biol
Chem 274: 37147–37153.
IGF Pathway in Salmon Muscle
PLoS ONE | www.plosone.org 14 June 2010 | Volume 5 | Issue 6 | e11100
